Understand the source comparison
VIP Daily Dose: Peptide Type Comparison
VIP (Vasoactive Intestinal Peptide) 2–10mg 2–4 doses per day 2–3 minutes VPAC1, VPAC2 Requires frequent dosing due to extremely short half-life. Once-daily administration fails to maintain therapeutic tissue levels beyond first hour Thymalin 10–30mg Once daily
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- VIP (Vasoactive Intestinal Peptide)
- 2–10mg
- 2–4 doses per day
- 2–3 minutes
- VPAC1, VPAC2
- Requires frequent dosing due to extremely short half-life. Once-daily administration fails to maintain therapeutic tissue levels beyond first hour
- Thymalin
- 10–30mg
- Once daily
- 2–4 hours
- Thymic epithelial receptors
- Longer half-life allows once-daily dosing for immune modulation research
- Cerebrolysin
- 5–30mL
- Once daily or 5 days per week
- 6–8 hours
- Neurotrophic pathways
- Sustained CNS effects permit once-daily administration in neuroprotection protocols
- Dihexa
- 1–5mg
- 2–3 hours
- HGF/c-Met pathway
- Oral bioavailability and moderate half-life support once-daily dosing
- Insulin
- 10–50 IU
- 1–4 doses per day
- 4–6 minutes
- Insulin receptor
- Similar short half-life to VIP but dosing matched to meals rather than continuous coverage